Sai Life Sciences Ltd.
Listed
NSE & BSE
Mainboard
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
27,710,560
50% |
50%
|
₹1,521.31 |
|
NII / HNI
|
Over 1.00x
|
8,313,169
15% |
15%
|
₹456.39 |
|
Retail
|
Over 1.00x
|
19,397,394
35% |
35%
|
₹1,064.92 |
| Total | 1.00x | 55,421,123 |
100% | ₹3,042.62 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 27,710,560 | ₹1,521.31 |
50.00%
|
| NII | 8,313,169 | ₹456.39 |
15.00%
|
| Retail | 19,397,394 | ₹1,064.92 |
35.00%
|
| Total | 55,421,123 | ₹3,042.62 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 8,313,169 | 19,397,394 | 27,710,563 |
| Allotment price (₹) | 549 | 549 | 549 | 549 | 549 | 549 | 549 | 549 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹1,064.92 | ₹1,064.92 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 8,313,169 | 19,397,394 | 27,710,563 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 54 | ₹29,646 |
| Retail (Max — 13 Lots) | 13 | 351 | ₹192,699 |
| S-HNI (Min — 14 Lots) | 14 | 378 | ₹207,522 |
| B-HNI (Min — 68 Lots) | 68 | 1,836 | ₹1,007,964 |
Sai Life Sciences Ltd. is proposing an IPO on NSE & BSE under the Mainboard category. Total issue: 5,54,21,123 shares (aggregating up to ₹3,042.62 Cr).
Opens 11 Dec 2024, closes 13 Dec 2024. Listing: 18 Dec 2024. Apply via ASBA or UPI.
| Particulars | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue from Operations | 693.35 | 1494.27 | 1245.11 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 28.01 | 82.81 | 9.99 |
| Net Worth | 1044.75 | 974.34 | 887.29 |
| Total Assets | 2476.78 | 2275.14 | 2186.65 |
| Reserves & Surplus | 1025.44 | 953.99 | 867.43 |
| Borrowings | 764.49 | 710.16 | 699.23 |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | 5.65% | — | — |
Sai Life Sciences Ltd. IPO is subscribed 1.00 times by Dec 13, 2024. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Sai Life Sciences Ltd. IPO retail category is subscribed 1.00 times as of 13 Dec 2024. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 11 Dec 2024 and closes 13 Dec 2024. Min investment: ₹14,823 (1 lot = 27 shares). UPI mandate: 2024-12-13.
The Sai Life Sciences Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 19 Dec 2024. Refunds: on 20 Dec 2024.
The Sai Life Sciences Ltd. IPO listing date is 18 Dec 2024, Wednesday. Listed on: NSE & BSE. Issue price: ₹549. Estimated listing: ₹549. GMP: NIL.
The Sai Life Sciences Ltd. IPO closes on 13 Dec 2024, Friday. UPI mandate: 2024-12-13. Allotment: 19 Dec 2024. Listing: 18 Dec 2024.